Malin Grönberg
Forskare vid Institutionen för medicinska vetenskaper; Onkologisk endokrinologi
- Telefon:
- 018-471 47 11, 018-471 47 14
- E-post:
- Malin.Gronberg@medsci.uu.se
- Besöksadress:
- Rudbecklaboratoriet, R3, vån 2
75185 Uppsala - Postadress:
- Rudbecklaboratoriet, R3, vån 2
75185 Uppsala
- Akademiska meriter:
- PhD, MSc
- ORCID:
- 0000-0003-4001-0572
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Nyckelord
- cancer
- ghrelin
- hormon
- neuroendocrine cancer
- peptides
- research
Biografi
Denna text finns inte på svenska, därför visas den engelska versionen.
My basic education is a M.Sc. in Biotechnology from SLU/Uppsala University.
I performed my Ph.D. in the field of Medical sciences at Uppsala University.
Forskning
Forskning avseende uttryck och funktion av olika peptidhormon i normal och neoplastisk vävnad.
Publikationer
Senaste publikationer
- Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy (2024)
- Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort (2023)
- Adrenalectomy in ectopic Cushing's syndrome (2021)
- Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2 (2021)
- PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3 (2020)
Alla publikationer
Artiklar
- Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy (2024)
- Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort (2023)
- Adrenalectomy in ectopic Cushing's syndrome (2021)
- Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2 (2021)
- PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3 (2020)
- Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3 (2020)
- Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome (2020)
- Intravenous versus Oral Etoposide (2018)
- Intravenous versus oral etoposide (2018)
- Ghrelin expression is associated with a favorable outcome in male breast cancer (2018)
- Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma (2017)
- A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors (2017)
- Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer (2017)
- Expression of Mutated p53 Protein in Gastroenteropancreatic Neuroendocrine Carcinoma (WHO G3) (2016)
- Ghrelin and Obestatin in Human Neuroendocrine Tumors (2013)
- Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer (2012)
- Neuroendocrine markers are expressed in human mammary glands (2010)
- Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays (2009)
- Distribution of obestatin and ghrelin in human tissues (2008)
- Somatostatin induces rapid contraction of neuroendocrine cells (2007)
- Expression of ghrelin is correlated to good outcome in invasive breast cancer
- Expression of ghrelin and obestatin in neuroendocrine tumors